Entyvio Eased Early Symptoms of Ulcerative Colitis and Crohn’s, New Analysis Shows

Entyvio Eased Early Symptoms of Ulcerative Colitis and Crohn’s, New Analysis Shows
Entyvio (vedolizumab) alleviated some of the early symptoms of patients with moderate to severe ulcerative colitis and Crohn’s disease, a new analysis of Phase 3 trial results indicates. Takeda Pharmaceutical presented the additional findings of the GEMINI clinical trial program, which covered 2,400 patients, at the World Congress of Gastroenterology in Orlando, Oct. 13-18. Two ulcerative colitis improvements that one poster presentation focused

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *